首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of alzheimers disease reports

缩写:

ISSN:N/A

e-ISSN:2542-4823

IF/分区:2.8/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引682
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Hafiz Khan,Fardous Farhana,Fahad Mostafa et al. Hafiz Khan et al.
Background: Alzheimer's disease (AD) is related to one or more chronic illnesses, which may develop cognitive decline and dementia. Cognitive impairment is increasing, and public health officials must address risk factors...
Ying Wang,Xinhua Song,Rui Wang et al. Ying Wang et al.
Background: Alzheimer's disease (AD) currently lacks effective disease-modifying treatments. Recent research suggests that ferroptosis could be a potential therapeutic target. Mendelian randomization (MR) is a widely used...
Sharareh Ehteshamzad Sharareh Ehteshamzad
Background: As the prevalence of Alzheimer's disease (AD) grows with an aging population, the need for early diagnosis has led to increased focus on electroencephalography (EEG) as a non-invasive diagnostic tool. ...
Md Ariful Islam,Sudhir Kshirsagar,Arubala P Reddy et al. Md Ariful Islam et al.
Several decades of research on cell and animal models contributed tremendously to understanding human diseases. Particularly, research on rodents and non-human primates revealed that animal research is a major and important component in bio...
Yiwen Yang,Ming Tong,Suzanne M de la Monte Yiwen Yang
Background: Alzheimer's disease (AD), one of the most prevalent causes of dementia, is mainly sporadic in occurrence but driven by aging and other cofactors. Studies suggest that excessive alcohol consumption may increase...
Marc L Gordon,Erica Christen,Lynda Keehlisen et al. Marc L Gordon et al.
We conducted a small, open-label, pilot study of daratumumab to explore target engagement, safety, and potential efficacy in patients with mild to moderate Alzheimer's disease. Daratumumab SC 1800 mg was given subcutaneously weekly for 8 we...
Rónán O&#x;Caoimh,Mary J Foley,Suzanne Timmons et al. Rónán O&#x;Caoimh et al.
Background: The Montreal Cognitive Assessment (MoCA) is recommended by the Movement Disorder Society for cognitive testing in movement disorders including Parkinson's disease (PD) and lewy body dementia. Few studies have ...
Azaz Bin Sharif,Ishrat Jahan,A B M Nahid Hasan Azaz Bin Sharif
Background: Alzheimer's disease (AD) is a growing public health concern affecting millions of individuals worldwide. This disease burden is exacerbated in countries like Bangladesh, where public awareness and knowledge ab...
Isaiah-Lorenzo De Guia,Shaun Eslick,Sharon L Naismith et al. Isaiah-Lorenzo De Guia et al.
Alzheimer's disease (AD) is the most common type of dementia, which is characterised by progressive memory loss and accumulation of hallmark markers amyloid-β (Aβ) and neurofibrillary tangles in the diseased brain. The current gold standa...
Ziqian Feng,Jiayu Wang,Lisi Xu et al. Ziqian Feng et al.
Background: Excessive daytime sleepiness (EDS) and caudate nucleus volume alterations have been linked to Alzheimer's disease (AD), but their relationship remains unclear under the context of subjective cognitive decline ...